| Baseline |  | |
---|---|---|---|
 | EID | Non-EID | p-value |
Patients, n (%) | 12 (32.4) | 25 (67.6) | Â |
WHO functional class, (%) | a | 0.09 | |
 II | 33.3 | 24 |  |
 III | 41.7 | 72 |  |
 IV | 25 | 4 |  |
6MWT | Â | Â | Â |
 6MWD (m) | 448.9 ± 206.8 | 383.6 ± 109.5 | 0.22 |
 Rest SpO2 (%) | 92.0 ± 2.2 | 94.8 ± 2.1 | 0.002 |
 Peak SpO2 (%) | 81.9 ± 4.4 | 92.1 ± 2.3 | 0.001 |
 Δ SpO2 (%) | 10.0 ± 1.1 | 2.7 ± 0.4 | 0.02 |
 Rest HR (beatsamin-1) | 83.5 ± 16.4 | 84 ± 13.7 | 0.9 |
 Peak HR (beatsamin-1) | 120.6 ± 20.7 | 115.5 ± 18.1 | 0.45 |
 Δ HR (beatsamin-1) | 30.5 ± 5.1 | 30.4 ± 2.4 | 0.82 |
 HRR (%) | 49.5 ± 8.1 | 42.5 ± 4 | 0.53 |
 Δ Borg | 4.7 ± 0.7 | 4.3 ± 0.5 | 0.52 |
 Supplemental Oxygen (n, %) | 4 (33.3) | 5 (20) a | 0.38 |
Lung function | Â | Â | Â |
 FEV1 (% pred.) | 83.6 ± 11.9 | 90.9 ± 14.1 | 0.15 |
 FEV1/FVC (% pred.) | 98.6 ± 10.2 | 94.8 ± 10.3 | 0.31 |
 TLC (% pred.) | 94.8 ± 16.3 | 100.8 ± 12.1 | 0.24 |
 VC (% pred.) | 85.8 ± 10.3 | 94.1 ± 14.4 | 0.1 |
RHC | Â | Â | |
 mPAP (mm Hg) | 43.8 ± 8.2 | 42.9 ± 9.0 | 0.77 |
 RAP (mm Hg) | 4.1 ± 2.7 | 6.6 ± 4.4 | 0.8 |
 PVR (dyneas/cm5) | 640.1 ± 231.0 | 587.4 ± 230.5 | 0.53 |
 CI (l/min/m2) | 2.5 ± 0.6 | 2.4 ± 0.5 | 0.7 |
 PAWP (mm Hg) | 9.3 ± 2.8 | 9.7 ± 5.4 | 0.8 |
Echocardiography | Â | Â | |
 TAPSE (mm) | 16.6 ± 4.3 | 17.4 ± 4.3 | 0.63 |
 PASP (mm Hg) | 77.2 ± 30.7 | 66.2 ± 21.7 | 0.24 |
CPETc | Â | Â | Â |
 Peak VO2 (ml/min/kg) | 13.1 ± 1.3 | 12.1 ± 0.6 | 0.65 |
 Rest VD/VT | 33.0 ± 7.3 | 36.0 ± 8 | 0.48 |
 Peak VD/VT | 39.0 ± 12.0 | 40.0 ± 7.3 | 0.78 |
 Rest VD, L | 0.41 ± 0.22 | 0.34 ± 0.14 | 0.4 |
 Peak VD, L | 0.67 ± 0.33 | 0.65 ± 0.23 | 0.9 |
Jamieson-Type, (%) | a | 0.72 | |
 I | 25 | 32 |  |
 II | 50 | 26 |  |
 III | 25 | 42 |  |
Laboratory | Â | Â | |
 NT-proBNP (pg/ml) | 414.0 [1260.2] | 836.7 [1521]b | 0.71 |